Efficace, Fabio
Stagno, Fabio
Iurlo, Alessandra
Breccia, Massimo
Cottone, Francesco
Bonifacio, Massimiliano http://orcid.org/0000-0003-0716-1686
Abruzzese, Elisabetta http://orcid.org/0000-0001-5228-6491
Castagnetti, Fausto
Caocci, Giovanni
Crugnola, Monica
Capodanno, Isabella
Martino, Bruno
Tiribelli, Mario http://orcid.org/0000-0001-9449-2621
Patriarca, Andrea
Gozzini, Antonella
Pregno, Patrizia
Saussele, Susanne
Cascavilla, Nicola
Fozza, Claudio
Bergamaschi, Micaela
Binotto, Gianni
Vignetti, Marco
Rosti, Gianantonio
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 2 May 2019
Revised: 12 June 2019
Accepted: 4 July 2019
First Online: 2 September 2019
Compliance with ethical standards
:
: FE: <i>Consultancy</i>: BMS, Amgen, Orsenix, Incyte and Takeda. MBr: <i>Honoraria</i>: Novartis, BMS, Pfizer, Incyte, Celgene. MBo: <i>Research funding</i>: Novartis; <i>Consultancy</i>: Bristol Myers Squibb. FCa: <i>Consultancy:</i> Novartis, Bristol Myers Squibb, Pfizer, Incyte; <i>Honoraria</i>: Novartis, Bristol Myers Squibb, Pfizer, Incyte. MC: <i>Honoraria:</i> Incyte, Novartis, Celgene, Amgen. AP: <i>Research funding:</i> Novartis. SS: <i>Research funding:</i> Novartis, Bristol Myers Squibb, Incyte; <i>Honoraria</i>: Novartis, Bristol Myers Squibb, Incyte, Pfizer. GB: <i>Honoraria:</i> Incyte, Pfizer, Bristol Myers Squibb, Novartis. GR: <i>Honoraria:</i> Novartis, Bristol Myers Squibb, Pfizer, Incyte. MV: <i>Consultancy</i> and <i>Advisory board</i>: Jazz Healthcare, Millennium Pharmaceuticals. <i>Educational meeting</i>: Pfizer